ONO 4127

Drug Profile

ONO 4127

Alternative Names: ONO 4127Na

Latest Information Update: 26 May 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ono Pharmaceutical
  • Class
  • Mechanism of Action Prostaglandin D2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Allergic rhinitis

Most Recent Events

  • 30 Apr 2006 Discontinued - Phase-I for Allergic rhinitis in United Kingdom (PO)
  • 18 May 2005 Ono Pharmaceutical has completed a Phase-I trial in Allergic rhinitis in the UK
  • 30 May 2003 Phase-I clinical trials in Allergic rhinitis in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top